Intersectoral cooperation to increase HPV vaccine coverage: an innovative collaboration between Managed Care Organizations and state-level stakeholders

In order to reduce disparities in human papillomavirus (HPV) vaccine coverage, intersectoral approaches are needed to reach vulnerable populations, including Medicaid enrollees. This manuscript describes a collaboration between Medicaid Managed Care Organizations (MCOs), the American Cancer Society,...

Full description

Saved in:
Bibliographic Details
Main Authors: Natoshia Askelson (Author), Grace Ryan (Author), Laura Seegmiller (Author), Alexander Preiss (Author), Sara Comstock (Author)
Format: Book
Published: Taylor & Francis Group, 2020-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_720b954e378e4cda82b3fa91399f26f9
042 |a dc 
100 1 0 |a Natoshia Askelson  |e author 
700 1 0 |a Grace Ryan  |e author 
700 1 0 |a Laura Seegmiller  |e author 
700 1 0 |a Alexander Preiss  |e author 
700 1 0 |a Sara Comstock  |e author 
245 0 0 |a Intersectoral cooperation to increase HPV vaccine coverage: an innovative collaboration between Managed Care Organizations and state-level stakeholders 
260 |b Taylor & Francis Group,   |c 2020-06-01T00:00:00Z. 
500 |a 2164-5515 
500 |a 2164-554X 
500 |a 10.1080/21645515.2019.1694814 
520 |a In order to reduce disparities in human papillomavirus (HPV) vaccine coverage, intersectoral approaches are needed to reach vulnerable populations, including Medicaid enrollees. This manuscript describes a collaboration between Medicaid Managed Care Organizations (MCOs), the American Cancer Society, and a state health department in a Midwestern state to address HPV vaccination. Qualitative interviews (n = 11) were conducted via telephone with key stakeholders from the three participating organizations using an interview guide designed to capture the process of developing the partnership and implementing the HPV-focused project. Interviews were transcribed and coded using thematic analysis. Interviewees described motivation to participate, including shared goals, and facilitators, like pooled resources. They cited barriers, such as time and legal challenges. Overall, interviewees reported that they believed this project is replicable. Conducting this project revealed the importance of shared vision, effective communication, and the complementary resources and experiences contributed by each organization. Valuable lessons were learned about reaching the Medicaid population and groundwork was laid for future efforts to serve vulnerable populations and reduce health disparities. This work has significant implications for other organizations seeking to partner with large nonprofits, state health departments, MCOs, or others, and the lessons learned from this project could be translated to other groups working to improve vaccination rates in their communities. 
546 |a EN 
690 |a managed care organizations 
690 |a intersectoral cooperation 
690 |a hpv vaccination 
690 |a cancer prevention 
690 |a medicaid 
690 |a Immunologic diseases. Allergy 
690 |a RC581-607 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Human Vaccines & Immunotherapeutics, Vol 16, Iss 6, Pp 1385-1391 (2020) 
787 0 |n http://dx.doi.org/10.1080/21645515.2019.1694814 
787 0 |n https://doaj.org/toc/2164-5515 
787 0 |n https://doaj.org/toc/2164-554X 
856 4 1 |u https://doaj.org/article/720b954e378e4cda82b3fa91399f26f9  |z Connect to this object online.